Hyperleptinemia independent of body adiposity in women with fibromyalgia

Rheumatology International

Volumn 34, Issue 11, 2014, Pages 1593-1598

  Homann, Diogo ^a   Carvalho, Humberto Moreira ^b   Stefanello, Joice Mara Facco ^a   Góes, Suelen Meira ^a   Lopes, André Luiz ^c   de Oliveira, Álvaro Reischak ^c   Leite, Neiva ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Chronic pain; Ghrelin; Leptin; Metabolism; Obesity

Indexed keywords

BIOLOGICAL MARKER; GHRELIN; GHRL PROTEIN, HUMAN; LEPTIN;

ADULT; BLOOD; BODY MASS; BRAZIL; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; FEMALE; FIBROMYALGIA; HUMAN; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PREVALENCE; STATISTICAL MODEL; UPREGULATION; WAIST CIRCUMFERENCE;

ADIPOSITY; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; BRAZIL; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FIBROMYALGIA; GHRELIN; HUMANS; LEPTIN; LINEAR MODELS; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; PREVALENCE; UP-REGULATION; WAIST CIRCUMFERENCE;

EID: 84896569770     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-2988-0     Document Type: Article

References (48)

1. Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, Gortmaker SL (2011) The global obesity pandemic: shaped by global drivers and local environments. Lancet 378:804–814
2. Kopelman PG (2000) Obesity as a medical problem. Nature 404:635–643
3. Peltonen M, Lindroos AK, Torgerson JS (2003) Musculoskeletal pain in the obese: a comparison with a general population and long-term changes after conventional and surgical obesity treatment. Pain 104:549–557
4. Yunus MB, Arslan S, Aldag JC (2002) Relationship between body mass index and fibromyalgia features. Scand J Rheumatol 31:27–31
5. Neumann L, Lerner E, Glazer Y, Bolotin A, Shefer A, Buskila D (2008) A cross-sectional study of the relationship between body mass index and clinical characteristics, tenderness measures, quality of life, and physical functioning in fibromyalgia patients. Clin Rheumatol 27:1543–1547
6. Mork PJ, Vasseljen O, Nilsen TI (2010) Association between physical exercise, body mass index, and risk of fibromyalgia: longitudinal data from the Norwegian Nord-Trondelag Health Study. Arthritis Care Res (Hoboken) 62:611–617
7. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L (2007) An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 8:27
8. Kim CH, Luedtke CA, Vincent A, Thompson JM, Oh TH (2012) The association of body mass index with symptom severity and quality of life in patients with fibromyalgia. Arthritis Care Res (Hoboken) 64:222–228
9. Ursini F, Naty S, Grembiale RD (2011) Fibromyalgia and obesity: the hidden link. Rheumatol Int 31:1403–1408
10. Suzuki K, Jayasena CN, Bloom SR (2012) Obesity and appetite control. Exp Diabetes Res 2012:824305
11. Kalra SP, Kalra PS (2010) Neuroendocrine control of energy homeostasis: update on new insights. Prog Brain Res 181:17–33
12. Fietta P, Fietta P (2006) Counterbalance between leptin and cortisol may be associated with fibromyalgia. Psychiatry Clin Neurosci 60:529
13. Tander B, Atmaca A, Aliyazicioglu Y, Canturk F (2007) Serum ghrelin levels but not GH, IGF-1 and IGFBP-3 levels are altered in patients with fibromyalgia syndrome. Joint Bone Spine 74:477–481
14. Scarpace PJ, Zhang Y (2007) Elevated leptin: consequence or cause of obesity? Front Biosci 12:3531–3544
15. Scerif M, Goldstone AP, Korbonits M (2011) Ghrelin in obesity and endocrine diseases. Mol Cell Endocrinol 340:15–25
16. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL et al (1996) Serum immunoreactive–leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292–295
17. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes 50:707–709
18. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S et al (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155–1161
19. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623–1630
20. Janke EA, Collins A, Kozak AT (2007) Overview of the relationship between pain and obesity: what do we know? Where do we go next? J Rehabil Res Dev 44:245–262
21. Lim G, Wang S, Zhang Y, Tian Y, Mao J (2009) Spinal leptin contributes to the pathogenesis of neuropathic pain in rodents. J Clin Invest 119:295–304
22. Tian Y, Wang S, Ma Y, Lim G, Kim H, Mao J (2011) Leptin enhances NMDA-induced spinal excitation in rats: a functional link between adipocytokine and neuropathic pain. Pain 152:1263–1271
23. Sibilia V, Lattuada N, Rapetti D, Pagani F, Vincenza D, Bulgarelli I, Locatelli V, Guidobono F, Netti C (2006) Ghrelin inhibits inflammatory pain in rats: involvement of the opioid system. Neuropharmacology 51:497–505
24. Vergnano AM, Ferrini F, Salio C, Lossi L, Baratta M, Merighi A (2008) The gastrointestinal hormone ghrelin modulates inhibitory neurotransmission in deep laminae of mouse spinal cord dorsal horn. Endocrinology 149:2306–2312
25. Guneli E, Onal A, Ates M, Bagriyanik HA, Resmi H, Orhan CE, Kolatan HE, Gumustekin M (2010) Effects of repeated administered ghrelin on chronic constriction injury of the sciatic nerve in rats. Neurosci Lett 479:226–230
26. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172
27. Lohman TG, Roche AF, Martorell R (1988) Anthropometric standardization reference manual. Human Kinetics Champaign, IL
28. Pardini R, Matsudo S, Araújo T, Matsudo V, Andrade E, Braggion G, Andrade D, Oliveira L, Figueira A Jr, Raso V (2001) Validation of the International Physical Activity Questionaire (IPAQ version 6): pilot study in Brazilian young adults. Rev Bras Ciênc Mov 9:45–51 [Portuguese]
29. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395
30. Hopkins WG (2002) A scale of magnitudes for effect statistics. http://www.sportsci.org/resource/stats/index.html. Accessed 10 Dec 2012
31. WHO (2012) Global health observatory data repository. Accessed 15 Nov 2012
32. Okifuji A, Donaldson GW, Barck L, Fine PG (2010) Relationship between fibromyalgia and obesity in pain, function, mood, and sleep. J Pain 11:1329–1337
33. Zhang S, Zhang Q, Zhang L, Li C, Jiang H (2013) Expression of ghrelin and leptin during the development of type 2 diabetes mellitus in a rat model. Mol Med Rep 7:223–228
34. Poykko SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O (2003) Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52:2546–2553
35. Franks PW, Brage S, Luan J, Ekelund U, Rahman M, Farooqi IS, Halsall I, O’Rahilly S, Wareham NJ (2005) Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obes Res 13:1476–1484
36. Ukkola O, Poykko SM, Antero Kesaniemi Y (2006) Low plasma ghrelin concentration is an indicator of the metabolic syndrome. Ann Med 38:274–279
37. Maeda T, Kiguchi N, Kobayashi Y, Ikuta T, Ozaki M, Kishioka S (2009) Leptin derived from adipocytes in injured peripheral nerves facilitates development of neuropathic pain via macrophage stimulation. Proc Natl Acad Sci USA 106:13076–13081
38. Bedaiwy MA, Falcone T, Goldberg JM, Sharma RK, Nelson DR, Agarwal A (2006) Peritoneal fluid leptin is associated with chronic pelvic pain but not infertility in endometriosis patients. Hum Reprod 21:788–791
39. Doupis J, Lyons TE, Wu S, Gnardellis C, Dinh T, Veves A (2009) Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab 94:2157–2163
40. Kim YS, Lee JS, Lee TH, Cho JY, Kim JO, Kim WJ, Kim HG, Jeon SR, Jeong HS (2012) Plasma levels of acylated ghrelin in patients with functional dyspepsia. World J Gastroenterol 18:2231–2237
41. Homann D, Louzada FM, Góes SM, Roizenblatt S, Lopes AL, de Oliveira AR, Leite N (2013) Acylated ghrelin: a potential marker for fibromyalgia? Eur J Pain 17:1216–1224
42. Petrenko AB, Yamakura T, Baba H, Shimoji K (2003) The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review. Anesth Analg 97:1108–1116
43. D’Mello R, Dickenson AH (2008) Spinal cord mechanisms of pain. Br J Anaesth 101:8–16
44. Scarpace PJ, Zhang Y (2009) Leptin resistance: a prediposing factor for diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 296:R493–R500
45. Van der Lely AJ, Tschöp M, Heiman ML, Ghigo E (2004) Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25:426–457
46. Cuatrecasas G, Gonzalez MJ, Alegre C, Sesmilo G, Fernandez-Solà J, Casanueva FF, Garcia-Fructuoso F, Poca-Dias V, Izquierdo JP, Puig-Domingo M (2010) High prevalence of growth hormone deficiency in severe fibromyalgia syndromes. J Clin Endocrinol Metab 95:4331–4337
47. Cuatrecasas G, Alegre C, Fernandez-Solà J, Gonzalez MJ, Garcia-Fructuoso F, Poca-Dias V, Nadal A, Cuatrecasas G, Navarro F, Mera A, Lage M, Peinó R, Casanueva F, Liñan C, Sesmilo G, Coves MJ, Izquierdo JP, Alvarez I, Granados E, Puig-Domingo M (2012) Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia. Pain 153:1382–1389
48. Camhi SM, Bray GA, Bouchard C, Greenway FL, Johnson WD, Newton RL, Ravussin E, Ryan DH, Smith SR, Katzmarzyk PT (2011) The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obesity (Silver Spring) 19:402–408